Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph R Podojil

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
The Journal of Clinical Investigation|May 4, 2026
Divergent Macrophage-Regulated T cell States Determine Response to Bacillus Calmette-Guérin vaccine in High-Risk Bladder CancerRyan J Brown, Mairah T Khan, Andrew J Houston, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 20, 2022
Tolerogenic Immune-Modifying Nanoparticles Encapsulating Multiple Recombinant Pancreatic β Cell Proteins Prevent Onset and Progression of Type 1 Diabetes in Nonobese Diabetic MiceJoseph R Podojil, Samantha Genardi, Ming-Yi Chiang, et al.
Journal of Autoimmunity|May 21, 2013
B7-H4Ig inhibits mouse and human T-cell function and treats EAE via IL-10/Treg-dependent mechanismsJoseph R Podojil, Linda N Liu, Shannon A Marshall, et al.
JCI Insight|June 23, 2022
Nanoparticles reduce monocytes within the lungs to improve outcomes after influenza virus infection in aged miceWilliam J Kelley, Kathleen M Wragg, Judy Chen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2006
Cutting Edge: Anti-CD25 monoclonal antibody injection results in the functional inactivation, not depletion, of CD4+CD25+ T regulatory cellsAdam P Kohm, Jeffrey S McMahon, Joseph R Podojil, et al.
Biotechnology and Bioengineering|October 12, 2022
Nanoparticle dose and antigen loading attenuate antigen-specific T-cell responsesLiam M Casey, Joseph T Decker, Joseph R Podojil, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 17, 2016
Cutting Edge: CD99 Is a Novel Therapeutic Target for Control of T Cell-Mediated Central Nervous System Autoimmune DiseaseRyan C Winger, Christopher T Harp, Ming-Yi Chiang, et al.
Frontiers in Allergy|April 7, 2022
Masked Delivery of Allergen in Nanoparticles Safely Attenuates Anaphylactic Response in Murine Models of Peanut AllergyKevin R Hughes, Michael N Saunders, Jeffrey J Landers, et al.
Brain : a Journal of Neurology|November 6, 2023
Interferon-γ controls aquaporin 4-specific Th17 and B cells in neuromyelitis optica spectrum disorderGabriel Arellano, Eileah Loda, Yanan Chen, et al.
Glia|February 10, 2025
AA147 Alleviates Symptoms in a Mouse Model of Multiple Sclerosis by Reducing Oligodendrocyte LossMetin Aksu, Kevin Kaschke, Joseph R Podojil, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
The Journal of Clinical Investigation|May 4, 2026
Divergent Macrophage-Regulated T cell States Determine Response to Bacillus Calmette-Guérin vaccine in High-Risk Bladder CancerRyan J Brown, Mairah T Khan, Andrew J Houston, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 20, 2022
Tolerogenic Immune-Modifying Nanoparticles Encapsulating Multiple Recombinant Pancreatic β Cell Proteins Prevent Onset and Progression of Type 1 Diabetes in Nonobese Diabetic MiceJoseph R Podojil, Samantha Genardi, Ming-Yi Chiang, et al.
Journal of Autoimmunity|May 21, 2013
B7-H4Ig inhibits mouse and human T-cell function and treats EAE via IL-10/Treg-dependent mechanismsJoseph R Podojil, Linda N Liu, Shannon A Marshall, et al.
JCI Insight|June 23, 2022
Nanoparticles reduce monocytes within the lungs to improve outcomes after influenza virus infection in aged miceWilliam J Kelley, Kathleen M Wragg, Judy Chen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2006
Cutting Edge: Anti-CD25 monoclonal antibody injection results in the functional inactivation, not depletion, of CD4+CD25+ T regulatory cellsAdam P Kohm, Jeffrey S McMahon, Joseph R Podojil, et al.
Biotechnology and Bioengineering|October 12, 2022
Nanoparticle dose and antigen loading attenuate antigen-specific T-cell responsesLiam M Casey, Joseph T Decker, Joseph R Podojil, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 17, 2016
Cutting Edge: CD99 Is a Novel Therapeutic Target for Control of T Cell-Mediated Central Nervous System Autoimmune DiseaseRyan C Winger, Christopher T Harp, Ming-Yi Chiang, et al.
Frontiers in Allergy|April 7, 2022
Masked Delivery of Allergen in Nanoparticles Safely Attenuates Anaphylactic Response in Murine Models of Peanut AllergyKevin R Hughes, Michael N Saunders, Jeffrey J Landers, et al.
Brain : a Journal of Neurology|November 6, 2023
Interferon-γ controls aquaporin 4-specific Th17 and B cells in neuromyelitis optica spectrum disorderGabriel Arellano, Eileah Loda, Yanan Chen, et al.
Glia|February 10, 2025
AA147 Alleviates Symptoms in a Mouse Model of Multiple Sclerosis by Reducing Oligodendrocyte LossMetin Aksu, Kevin Kaschke, Joseph R Podojil, et al.
Pageof 6